Accelerant Announces Third Quarter 2025 Results
-
Exchange Written Premium of
$1.043 billion grew 17% year-over-year and 39% on a year-to-date basis -
Net loss of
$1.367 billion driven by non-cash and equity-neutral profits interest distribution expenses -
Adjusted net income of
$79.8 million , up 320% over the prior year -
Net loss per basic and diluted share of
$6.99 , adjusted earnings per diluted share of$0.38 -
Adjusted EBITDA of
$105.0 million and$66.3 million when excluding in-period investment gains (Adjusted EBITDA was up 302% year-over-year and 164% when excluding the investment gains) - Additional key measures are presented below
“We delivered a strong third quarter, reflecting the continued momentum across our platform,” said
“Our third quarter results underscore the scalability of our model and the quality of our earnings,” said
Third Quarter 2025 Key Results
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
(in millions, unless indicated) |
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Number of members |
|
265 |
|
|
|
204 |
|
|
|
265 |
|
|
|
204 |
|
|
Net revenue retention |
|
135 |
% |
|
|
146 |
% |
|
|
135 |
% |
|
|
146 |
% |
|
Exchange written premium |
$ |
1,042.9 |
|
|
$ |
888.4 |
|
|
$ |
3,100.4 |
|
|
$ |
2,229.0 |
|
|
Accelerant direct written premium |
|
68 |
% |
|
|
79 |
% |
|
|
74 |
% |
|
|
86 |
% |
|
Third-party direct written premium |
|
32 |
% |
|
|
21 |
% |
|
|
26 |
% |
|
|
14 |
% |
|
Accelerant-retained exchange premium |
|
7 |
% |
|
|
10 |
% |
|
|
7 |
% |
|
|
10 |
% |
|
Exchange written premium growth rate |
|
17 |
% |
|
|
94 |
% |
|
|
39 |
% |
|
|
84 |
% |
|
Total revenues |
$ |
267.4 |
|
|
$ |
153.7 |
|
|
$ |
664.5 |
|
|
$ |
411.9 |
|
|
Gross loss ratio |
|
50.1 |
% |
|
|
51.8 |
% |
|
|
51.2 |
% |
|
|
52.8 |
% |
|
(Loss) income before income taxes |
$ |
(1,357.5 |
) |
|
$ |
1.3 |
|
|
$ |
(1,319.7 |
) |
|
$ |
9.0 |
|
|
Net (loss) income |
$ |
(1,367.0 |
) |
|
$ |
9.4 |
|
|
$ |
(1,346.1 |
) |
|
$ |
2.3 |
|
|
Non-GAAP financial measures (1) |
|
|
|
|
|
|
|
||||||||
|
Adjusted net income (1) |
$ |
79.8 |
|
|
$ |
19.0 |
|
|
$ |
127.5 |
|
|
$ |
27.3 |
|
|
Adjusted EBITDA (1) |
$ |
105.0 |
|
|
$ |
26.1 |
|
|
$ |
211.3 |
|
|
$ |
66.6 |
|
|
Adjusted EBITDA margin (1) |
|
39 |
% |
|
|
17 |
% |
|
|
32 |
% |
|
|
16 |
% |
|
(1) |
The definitions of Adjusted Net Income, Adjusted EBITDA, Adjusted earnings per diluted share and Adjusted EBITDA margin can be found in the "Use of Non-GAAP Financial Measures" section of this release. A reconciliation of Adjusted Net Income, Adjusted EBITDA and Adjusted EBITDA margin to the most directly comparable GAAP measures can be found on page 12. |
Conference Call Information
Accelerant will host a webcast and conference call to discuss the third quarter financial results on
A webcast replay of the call will be available on Accelerant's website at accelerant.ai in its Investors section for one year following the call.
About Accelerant
Accelerant is a data-driven Risk Exchange connecting underwriters of specialty insurance risk with risk capital providers. Accelerant was founded in 2018 by a group of longtime insurance industry executives and technology experts who shared a vision of rebuilding the way risk is exchanged – so that it works better, for everyone. The Accelerant Risk Exchange does business across 22 different countries and more than 500 specialty insurance products.
The Company generates revenue by charging fees on the Exchange Written Premium shared with
Forward-Looking Statements
All statements in this release and in the corresponding earnings call that are not historical are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties. You can generally identify forward-looking statements by our use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “projection,” “seek,” “should,” “will” or “would,” or the negative thereof or other variations thereon or comparable terminology. In particular, statements about the markets in which we operate, including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions or future events or performance contained in this release and in the corresponding earnings call are forward-looking statements.
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed in our Quarterly Report on Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements, or could affect our share price.
Use of Non-GAAP Financial Measures
In assessing the performance of our business, non-GAAP financial measures are used that are derived from our consolidated financial information but are not presented in our consolidated financial statements prepared in accordance with GAAP. We consider these non-GAAP financial measures to be useful metrics for management and investors to evaluate our financial performance by excluding certain items that are related to our non-core business operations and therefore are not considered to be directly attributable to our underlying operating performance.
Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income (Loss) and Adjusted earnings per diluted share should not be considered substitutes for the reported results prepared in accordance with GAAP and should not be considered in isolation or as alternatives to GAAP net income or net (loss) as indicators of our financial performance. Although we use Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income (Loss) and Adjusted earnings per diluted share as financial measures to assess the performance of our business, such use is limited because it does not include certain material costs necessary to operate our business. Our presentation of Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income (Loss) and Adjusted earnings per diluted share should not be construed as indications that our future results will be unaffected by unusual or non-recurring items. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures reported by other companies. Set forth below are reconciliations of our most directly comparable financial measures calculated in accordance with GAAP to these non-GAAP financial measures on a consolidated basis.
Adjusted EBITDA and Adjusted Net Income (Loss)
We define Adjusted EBITDA as GAAP net income (loss) less the impact of depreciation and amortization, interest expenses, income tax expenses and the following items:
- Other expenses: Represents costs related to our non-core business operations, primarily related to our global enterprise resource planning system and integrated financial reporting systems, and legal and advisory costs in connection with corporate development activities including mergers and acquisitions, capital raising activities and entity formations that support our growing business.
-
Nonrecurring profit interest distribution expenses resulting from the IPO: Represents non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by
Accelerant Holdings LP to certain officers and employees of the Company that fully vested upon the IPO. These expenses were entirely offset by a corresponding capital contribution for that distribution of shares. These expenses only occurred at one point in time and will not recur.
- Share-based compensation expenses included within general and administrative expenses: Represents non-cash expense related to the fair value of share-based awards granted to employees and directors, including restricted stock units and stock options and other awards that can be settled in cash, recognized over the requisite service period for the awards.
- Net foreign currency exchange gains (losses): The functional currency for each of our operating subsidiaries is generally the currency of the local operating environment. Transactions in currencies other than the local operation’s functional currency are remeasured into the functional currency, and the resulting foreign exchange gains or losses are reflected in net foreign currency exchange gains (losses). Such gains and losses are generally offset by the translation of our subsidiaries who have the corresponding reinsurance-related balances within their own functional currencies, whereby such effects are translated to other comprehensive income, yielding a much lower net impact on total comprehensive income and equity.
We define Adjusted Net Income (Loss) as GAAP net income (loss) less the impact of other expenses, nonrecurring profits interest distribution expenses, share-based compensation expenses and the tax effect of the adjustments for other expenses (such measure differs from Adjusted EBITDA as it includes the effect of interest, taxes, depreciation and amortization, as well as foreign currency exchange gains (losses)). Adjusted earnings per diluted share is calculated as adjusted net income for the respective periods divided by the sum of US GAAP basis diluted shares presented herein and certain dilutive restricted stock units which added 2,963,668 shares for the three months ended
Adjusted EBITDA Margin
We define Adjusted EBITDA margin, a non-GAAP financial measure, as Adjusted EBITDA divided by total revenue. Adjusted EBITDA margin is an internal performance measure used in the management of our operations.
The reconciliation of the above non-GAAP measures to each of their most directly comparable GAAP financial measures is set forth in the reconciliation table accompanying this release.
|
Consolidated Statements of Operations (in millions, except per share amounts) (unaudited) |
|||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
(expressed in millions of US dollars, except share data) |
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Revenues |
|
|
|
|
|
|
|
||||||||
|
Ceding commission income |
$ |
92.3 |
|
|
$ |
62.1 |
|
|
$ |
264.6 |
|
|
$ |
186.2 |
|
|
Direct commission income |
|
43.4 |
|
|
|
17.2 |
|
|
|
105.7 |
|
|
|
38.9 |
|
|
Net earned premiums |
|
82.1 |
|
|
|
59.3 |
|
|
|
215.7 |
|
|
|
155.5 |
|
|
Net investment income |
|
10.1 |
|
|
|
11.0 |
|
|
|
35.1 |
|
|
|
27.6 |
|
|
Net realized gains on investments |
|
3.5 |
|
|
|
0.1 |
|
|
|
6.2 |
|
|
|
0.5 |
|
|
Net unrealized gains on investments |
|
36.0 |
|
|
|
4.0 |
|
|
|
37.2 |
|
|
|
3.2 |
|
|
Total revenues |
|
267.4 |
|
|
|
153.7 |
|
|
|
664.5 |
|
|
|
411.9 |
|
|
Expenses |
|
|
|
|
|
|
|
||||||||
|
Losses and loss adjustment expenses |
|
50.8 |
|
|
|
39.7 |
|
|
|
147.3 |
|
|
|
111.6 |
|
|
Amortization of deferred acquisition costs |
|
22.8 |
|
|
|
23.1 |
|
|
|
58.1 |
|
|
|
62.0 |
|
|
General and administrative expenses |
|
115.8 |
|
|
|
67.3 |
|
|
|
280.2 |
|
|
|
178.0 |
|
|
Interest expenses |
|
2.6 |
|
|
|
3.1 |
|
|
|
7.7 |
|
|
|
9.1 |
|
|
Depreciation and amortization |
|
10.0 |
|
|
|
5.8 |
|
|
|
25.7 |
|
|
|
16.2 |
|
|
Profit interest distribution expenses |
|
1,379.7 |
|
|
|
— |
|
|
|
1,379.7 |
|
|
|
— |
|
|
Net foreign exchange (gains) losses |
|
(2.4 |
) |
|
|
5.4 |
|
|
|
14.9 |
|
|
|
3.6 |
|
|
Other expenses |
|
45.6 |
|
|
|
8.0 |
|
|
|
70.6 |
|
|
|
22.4 |
|
|
Total expenses |
|
1,624.9 |
|
|
|
152.4 |
|
|
|
1,984.2 |
|
|
|
402.9 |
|
|
(Loss) income before income taxes |
|
(1,357.5 |
) |
|
|
1.3 |
|
|
|
(1,319.7 |
) |
|
|
9.0 |
|
|
Income tax (expense) benefit |
|
(9.5 |
) |
|
|
8.1 |
|
|
|
(26.4 |
) |
|
|
(6.7 |
) |
|
Net (loss) income |
|
(1,367.0 |
) |
|
|
9.4 |
|
|
|
(1,346.1 |
) |
|
|
2.3 |
|
|
Adjustment for net (income) loss attributable to non-controlling interests |
|
(1.8 |
) |
|
|
(1.3 |
) |
|
|
(7.4 |
) |
|
|
3.9 |
|
|
Deemed dividend upon redemption of Class C preference shares |
|
(70.9 |
) |
|
|
— |
|
|
|
(70.9 |
) |
|
|
— |
|
|
Net (loss) income attributable to Accelerant common shareholders |
$ |
(1,439.7 |
) |
|
$ |
8.1 |
|
|
$ |
(1,424.4 |
) |
|
$ |
6.2 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net (loss) income attributable to Accelerant per common share: |
|
|
|
|
|
|
|
||||||||
|
Basic |
$ |
(6.99 |
) |
|
$ |
0.05 |
|
|
$ |
(7.93 |
) |
|
$ |
0.04 |
|
|
Diluted |
$ |
(6.99 |
) |
|
$ |
0.04 |
|
|
$ |
(7.93 |
) |
|
$ |
0.03 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
||||||||
|
Basic |
|
206,064,119 |
|
|
|
166,185,094 |
|
|
|
179,624,179 |
|
|
|
165,913,933 |
|
|
Diluted |
|
206,064,119 |
|
|
|
199,710,283 |
|
|
|
179,624,179 |
|
|
|
199,384,420 |
|
|
Consolidated Balance Sheets (in millions, except par value) (unaudited) |
|||||||
|
|
|
|
|
||||
|
(expressed in millions of US dollars, except share data) |
|
|
|
||||
|
Assets |
|
|
|
||||
|
Investments |
|
|
|
||||
|
Short-term investments available for sale, at fair value
(amortized cost 2025: |
$ |
64.8 |
|
|
$ |
64.8 |
|
|
Fixed maturity securities available for sale, at fair value
(amortized cost 2025: |
|
721.9 |
|
|
|
479.5 |
|
|
Equity method investments |
|
9.4 |
|
|
|
18.2 |
|
|
Other investments |
|
81.7 |
|
|
|
45.3 |
|
|
Total investments |
|
877.8 |
|
|
|
607.8 |
|
|
Cash, cash equivalents and restricted cash |
|
1,675.9 |
|
|
|
1,273.0 |
|
|
Premiums receivable (net of allowance 2025: |
|
922.0 |
|
|
|
791.9 |
|
|
Ceded unearned premiums |
|
1,868.0 |
|
|
|
1,558.4 |
|
|
Reinsurance recoverables on unpaid losses and LAE |
|
1,552.9 |
|
|
|
1,069.5 |
|
|
Other reinsurance recoverables |
|
527.1 |
|
|
|
364.3 |
|
|
Deferred acquisition costs |
|
59.0 |
|
|
|
60.7 |
|
|
|
|
116.5 |
|
|
|
64.0 |
|
|
Capitalized technology development costs, net |
|
95.7 |
|
|
|
83.6 |
|
|
Other assets |
|
164.5 |
|
|
|
221.7 |
|
|
Total assets |
$ |
7,859.4 |
|
|
$ |
6,094.9 |
|
|
Liabilities and shareholders' equity |
|
|
|
||||
|
Unpaid losses and loss adjustment expenses |
$ |
1,841.4 |
|
|
$ |
1,294.4 |
|
|
Unearned premiums |
|
2,167.5 |
|
|
|
1,803.2 |
|
|
Payables to reinsurers |
|
1,219.5 |
|
|
|
1,109.0 |
|
|
Deferred ceding commissions |
|
226.0 |
|
|
|
193.0 |
|
|
Funds held under reinsurance |
|
1,132.5 |
|
|
|
746.9 |
|
|
Insurance balances payable |
|
173.5 |
|
|
|
148.0 |
|
|
Debt |
|
121.9 |
|
|
|
121.4 |
|
|
Accounts payable and other liabilities |
|
273.3 |
|
|
|
252.0 |
|
|
Total liabilities |
|
7,155.6 |
|
|
|
5,667.9 |
|
|
Commitments and contingencies (Note 18) |
|
|
|
||||
|
Equity |
|
|
|
||||
|
Redeemable preference shares |
|
|
|
||||
|
Class C convertible preference shares (issued and outstanding 2024: 5,556,546) |
|
— |
|
|
|
104.4 |
|
|
Shareholders' equity |
|
|
|
||||
|
Convertible preference shares: |
|
|
|
||||
|
Class A (issued and outstanding 2024: 20,955,497) |
|
— |
|
|
|
236.7 |
|
|
Class B (issued and outstanding 2024: 12,569,691) |
|
— |
|
|
|
145.1 |
|
|
Common shares (par value 2025: Class A - 114,578,616; Class B - 107,241,428 and 2024: 166,185,094) |
|
— |
|
|
|
— |
|
|
Additional paid-in capital |
|
2,213.9 |
|
|
|
124.8 |
|
|
Accumulated other comprehensive loss |
|
(1.5 |
) |
|
|
(19.5 |
) |
|
Accumulated deficit |
|
(1,536.3 |
) |
|
|
(182.8 |
) |
|
Total Accelerant shareholders' equity |
|
676.1 |
|
|
|
304.3 |
|
|
Non-controlling interests |
|
27.7 |
|
|
|
18.3 |
|
|
Total equity |
|
703.8 |
|
|
|
427.0 |
|
|
Total liabilities and equity |
$ |
7,859.4 |
|
|
$ |
6,094.9 |
|
|
Consolidated Statements of Cash Flows (in millions) (unaudited) |
|||||||
|
|
Nine Months Ended |
||||||
|
(expressed in millions of US dollars) |
|
2025 |
|
|
|
2024 |
|
|
Cash flows from operating activities |
|
|
|
||||
|
Net (loss) income |
$ |
(1,346.1 |
) |
|
$ |
2.3 |
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
||||
|
Non-cash revenues, expenses, gains and losses included in net income: |
|
|
|
||||
|
Profits interest distribution expenses |
|
1,379.7 |
|
|
|
— |
|
|
Net realized gains on investments |
|
(6.2 |
) |
|
|
(0.5 |
) |
|
Net unrealized gains on investments |
|
(37.2 |
) |
|
|
(3.2 |
) |
|
Earnings from equity method investments |
|
(1.5 |
) |
|
|
(1.7 |
) |
|
Share-based compensation expenses |
|
22.6 |
|
|
|
6.3 |
|
|
Depreciation and amortization |
|
25.7 |
|
|
|
16.2 |
|
|
Deferred income tax benefit |
|
(11.8 |
) |
|
|
(35.6 |
) |
|
Net foreign exchange losses |
|
14.9 |
|
|
|
3.6 |
|
|
Net accretion of discount on fixed maturity securities and short-term investments |
|
(5.9 |
) |
|
|
(3.9 |
) |
|
Other, net |
|
2.8 |
|
|
|
1.0 |
|
|
Changes in operating assets and liabilities: |
|
|
|
||||
|
Premiums receivable |
|
(102.7 |
) |
|
|
(212.7 |
) |
|
Ceded unearned premiums |
|
(280.6 |
) |
|
|
(481.1 |
) |
|
Reinsurance recoverables on unpaid losses and LAE |
|
(460.5 |
) |
|
|
(314.8 |
) |
|
Other reinsurance recoverables |
|
(152.8 |
) |
|
|
(39.0 |
) |
|
Deferred acquisition costs |
|
1.9 |
|
|
|
(10.2 |
) |
|
Unpaid losses and loss adjustment expenses |
|
483.6 |
|
|
|
340.1 |
|
|
Unearned premiums |
|
292.1 |
|
|
|
489.6 |
|
|
Payables to reinsurers |
|
86.3 |
|
|
|
505.2 |
|
|
Deferred ceding commissions |
|
48.7 |
|
|
|
64.9 |
|
|
Funds held under reinsurance |
|
383.1 |
|
|
|
164.7 |
|
|
Insurance balances payable |
|
23.4 |
|
|
|
13.3 |
|
|
Other assets, accounts payable and other liabilities |
|
23.7 |
|
|
|
39.4 |
|
|
Net cash provided by operating activities |
|
383.2 |
|
|
|
543.9 |
|
|
Cash flows from investing activities |
|
|
|
||||
|
Proceeds from sales of: |
|
|
|
||||
|
Equity securities |
|
— |
|
|
|
115.2 |
|
|
Fixed maturity securities |
|
150.8 |
|
|
|
21.6 |
|
|
Equity method investments |
|
1.1 |
|
|
|
— |
|
|
Other investments |
|
3.6 |
|
|
|
0.3 |
|
|
Maturities of fixed maturity securities |
|
40.0 |
|
|
|
14.8 |
|
|
Payments for purchases of: |
|
|
|
||||
|
Fixed maturity securities |
|
(397.9 |
) |
|
|
(313.5 |
) |
|
Equity method investments |
|
(0.8 |
) |
|
|
(4.1 |
) |
|
Net change in short-term investments |
|
4.9 |
|
|
|
(39.4 |
) |
|
Purchases of subsidiaries, net of cash acquired |
|
(9.9 |
) |
|
|
— |
|
|
Capitalized technology development expenditures |
|
(29.8 |
) |
|
|
(25.3 |
) |
|
Other, net |
|
(0.3 |
) |
|
|
(0.8 |
) |
|
Net cash used in investing activities |
|
(238.3 |
) |
|
|
(231.2 |
) |
|
Cash flows from financing activities |
|
|
|
||||
|
Redemption of Class C convertible preference shares |
|
(175.3 |
) |
|
|
— |
|
|
Issuance of common shares, net of issuance costs |
|
392.0 |
|
|
|
— |
|
|
Credit facility borrowings |
|
5.0 |
|
|
|
— |
|
|
Credit facility repayment |
|
(5.0 |
) |
|
|
— |
|
|
Issuance of debt, net of issuance costs |
|
— |
|
|
|
49.7 |
|
|
Payment of debt |
|
— |
|
|
|
(50.4 |
) |
|
Dividends paid to non-controlling interests |
|
(7.2 |
) |
|
|
(2.7 |
) |
|
Net cash provided by (used in) financing activities |
|
209.5 |
|
|
|
(3.4 |
) |
|
Net increase in cash, cash equivalents and restricted cash |
|
354.4 |
|
|
|
309.3 |
|
|
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash |
|
48.5 |
|
|
|
0.3 |
|
|
Cash, cash equivalents and restricted cash at beginning of period |
|
1,273.0 |
|
|
|
775.4 |
|
|
Cash, cash equivalents and restricted cash at end of period |
$ |
1,675.9 |
|
|
$ |
1,085.0 |
|
|
Financial Information by Segment (in millions) (unaudited) |
|||||||||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||||||
|
(in millions) |
|
|
MGA Operations |
|
Underwriting |
|
Total Segments |
|
Corporate and Other |
|
Consolidation and elimination adjustments |
|
Total |
||||||||||
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Ceding commission income |
$ |
— |
|
$ |
— |
|
$ |
29.0 |
|
$ |
29.0 |
|
$ |
— |
|
|
$ |
63.3 |
|
|
$ |
92.3 |
|
|
Direct commission income |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Affiliated entities |
|
61.1 |
|
|
28.5 |
|
|
— |
|
|
89.6 |
|
|
— |
|
|
|
(89.6 |
) |
|
|
— |
|
|
Unaffiliated entities |
|
22.8 |
|
|
20.6 |
|
|
— |
|
|
43.4 |
|
|
— |
|
|
|
— |
|
|
|
43.4 |
|
|
Net earned premiums |
|
— |
|
|
— |
|
|
82.1 |
|
|
82.1 |
|
|
— |
|
|
|
— |
|
|
|
82.1 |
|
|
Net investment income |
|
1.1 |
|
|
1.0 |
|
|
6.1 |
|
|
8.2 |
|
|
1.9 |
|
|
|
— |
|
|
|
10.1 |
|
|
Net realized gains on investments |
|
— |
|
|
3.1 |
|
|
0.4 |
|
|
3.5 |
|
|
— |
|
|
|
— |
|
|
|
3.5 |
|
|
Net unrealized gains on investments |
|
— |
|
|
27.6 |
|
|
— |
|
|
27.6 |
|
|
8.4 |
|
|
|
— |
|
|
|
36.0 |
|
|
Segment revenues |
|
85.0 |
|
|
80.8 |
|
|
117.6 |
|
|
283.4 |
|
|
10.3 |
|
|
|
(26.3 |
) |
|
|
267.4 |
|
|
Losses and loss adjustment expenses |
|
— |
|
|
— |
|
|
50.8 |
|
|
50.8 |
|
|
— |
|
|
|
— |
|
|
|
50.8 |
|
|
Amortization of deferred acquisition costs |
|
— |
|
|
— |
|
|
34.9 |
|
|
34.9 |
|
|
— |
|
|
|
(12.1 |
) |
|
|
22.8 |
|
|
General and administrative expenses |
|
25.8 |
|
|
35.4 |
|
|
14.3 |
|
|
75.5 |
|
|
23.6 |
|
|
|
(10.3 |
) |
|
|
88.8 |
|
|
Adjusted EBITDA |
$ |
59.2 |
|
$ |
45.4 |
|
$ |
17.6 |
|
$ |
122.2 |
|
$ |
(13.3 |
) |
|
$ |
(3.9 |
) |
|
|
105.0 |
|
|
Interest expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(2.6 |
) |
||||||||
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
(10.0 |
) |
||||||||
|
Profits interest distribution expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,379.7 |
) |
||||||||
|
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(27.0 |
) |
||||||||
|
Net foreign exchange gains |
|
|
|
|
|
|
|
|
|
|
|
|
|
2.4 |
|
||||||||
|
Other expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(45.6 |
) |
||||||||
|
Loss before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(1,357.5 |
) |
||||||||
|
Financial Information by Segment (continued) (in millions) (unaudited) |
||||||||||||||||||||||||
|
|
Three Months Ended |
|||||||||||||||||||||||
|
(in millions) |
|
|
MGA Operations |
|
Underwriting |
|
Total Segments |
|
Corporate and Other |
|
Consolidation and elimination adjustments |
|
Total |
|||||||||||
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Ceding commission income |
$ |
— |
|
$ |
— |
|
$ |
15.4 |
|
|
$ |
15.4 |
|
$ |
— |
|
|
$ |
46.7 |
|
|
$ |
62.1 |
|
|
Direct commission income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Affiliated entities |
|
55.5 |
|
|
32.3 |
|
|
— |
|
|
|
87.8 |
|
|
— |
|
|
|
(87.8 |
) |
|
|
— |
|
|
Unaffiliated entities |
|
7.7 |
|
|
9.5 |
|
|
— |
|
|
|
17.2 |
|
|
— |
|
|
|
— |
|
|
|
17.2 |
|
|
Net earned premiums |
|
— |
|
|
— |
|
|
59.3 |
|
|
|
59.3 |
|
|
— |
|
|
|
— |
|
|
|
59.3 |
|
|
Net investment income |
|
0.4 |
|
|
1.1 |
|
|
8.9 |
|
|
|
10.4 |
|
|
0.6 |
|
|
|
— |
|
|
|
11.0 |
|
|
Net realized gains on investments |
|
— |
|
|
— |
|
|
0.1 |
|
|
|
0.1 |
|
|
— |
|
|
|
— |
|
|
|
0.1 |
|
|
Net unrealized gains on investments |
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
4.0 |
|
|
|
— |
|
|
|
4.0 |
|
|
Segment revenues |
|
63.6 |
|
|
42.9 |
|
|
83.7 |
|
|
|
190.2 |
|
|
4.6 |
|
|
|
(41.1 |
) |
|
|
153.7 |
|
|
Losses and loss adjustment expenses |
|
— |
|
|
— |
|
|
39.7 |
|
|
|
39.7 |
|
|
— |
|
|
|
— |
|
|
|
39.7 |
|
|
Amortization of deferred acquisition costs |
|
— |
|
|
— |
|
|
30.1 |
|
|
|
30.1 |
|
|
— |
|
|
|
(7.0 |
) |
|
|
23.1 |
|
|
General and administrative expenses |
|
18.0 |
|
|
25.2 |
|
|
31.5 |
|
|
|
74.7 |
|
|
6.7 |
|
|
|
(16.6 |
) |
|
|
64.8 |
|
|
Adjusted EBITDA |
$ |
45.6 |
|
$ |
17.7 |
|
$ |
(17.6 |
) |
|
$ |
45.7 |
|
$ |
(2.1 |
) |
|
$ |
(17.5 |
) |
|
$ |
26.1 |
|
|
Interest expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(3.1 |
) |
|||||||||
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
(5.8 |
) |
|||||||||
|
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(2.5 |
) |
|||||||||
|
Net foreign exchange losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(5.4 |
) |
|||||||||
|
Other expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.0 |
) |
|||||||||
|
Income before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1.3 |
|
|||||||||
|
Financial Information by Segment (continued) (in millions) (unaudited) |
|||||||||||||||||||||||
|
|
Nine Months Ended |
||||||||||||||||||||||
|
(in millions) |
|
|
MGA Operations |
|
Underwriting |
|
Total Segments |
|
Corporate and Other |
|
Consolidation and elimination adjustments |
|
Total |
||||||||||
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Ceding commission income |
$ |
— |
|
$ |
— |
|
$ |
77.8 |
|
$ |
77.8 |
|
$ |
— |
|
|
$ |
186.8 |
|
|
$ |
264.6 |
|
|
Direct commission income |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Affiliated entities |
|
189.1 |
|
|
99.0 |
|
|
— |
|
|
288.1 |
|
|
— |
|
|
|
(288.1 |
) |
|
|
— |
|
|
Unaffiliated entities |
|
49.6 |
|
|
56.1 |
|
|
— |
|
|
105.7 |
|
|
— |
|
|
|
— |
|
|
|
105.7 |
|
|
Net earned premiums |
|
— |
|
|
— |
|
|
215.7 |
|
|
215.7 |
|
|
— |
|
|
|
— |
|
|
|
215.7 |
|
|
Net investment income |
|
2.8 |
|
|
2.8 |
|
|
25.8 |
|
|
31.4 |
|
|
3.7 |
|
|
|
— |
|
|
|
35.1 |
|
|
Net realized gains on investments |
|
— |
|
|
5.2 |
|
|
1.0 |
|
|
6.2 |
|
|
— |
|
|
|
— |
|
|
|
6.2 |
|
|
Net unrealized gains on investments |
|
— |
|
|
27.1 |
|
|
— |
|
|
27.1 |
|
|
10.1 |
|
|
|
— |
|
|
|
37.2 |
|
|
Segment revenues |
|
241.5 |
|
|
190.2 |
|
|
320.3 |
|
|
752.0 |
|
|
13.8 |
|
|
|
(101.3 |
) |
|
|
664.5 |
|
|
Losses and loss adjustment expenses |
|
— |
|
|
— |
|
|
147.3 |
|
|
147.3 |
|
|
— |
|
|
|
— |
|
|
|
147.3 |
|
|
Amortization of deferred acquisition costs |
|
— |
|
|
— |
|
|
87.6 |
|
|
87.6 |
|
|
— |
|
|
|
(29.5 |
) |
|
|
58.1 |
|
|
General and administrative expenses |
|
79.6 |
|
|
100.4 |
|
|
40.6 |
|
|
220.6 |
|
|
54.5 |
|
|
|
(27.3 |
) |
|
|
247.8 |
|
|
Adjusted EBITDA |
$ |
161.9 |
|
$ |
89.8 |
|
$ |
44.8 |
|
$ |
296.5 |
|
$ |
(40.7 |
) |
|
$ |
(44.5 |
) |
|
$ |
211.3 |
|
|
Interest expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(7.7 |
) |
||||||||
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
(25.7 |
) |
||||||||
|
Profits interest distribution expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,379.7 |
) |
||||||||
|
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(32.4 |
) |
||||||||
|
Net foreign exchange losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(14.9 |
) |
||||||||
|
Other expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(70.6 |
) |
||||||||
|
Loss before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(1,319.7 |
) |
||||||||
|
Financial Information by Segment (continued) (in millions) (unaudited) |
|||||||||||||||||||||||||
|
|
Nine Months Ended |
||||||||||||||||||||||||
|
(in millions) |
|
|
MGA Operations |
|
Underwriting |
|
Total Segments |
|
Corporate and Other |
|
Consolidation and elimination adjustments |
|
Total |
||||||||||||
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Ceding commission income |
$ |
— |
|
$ |
— |
|
$ |
65.0 |
|
|
$ |
65.0 |
|
|
$ |
— |
|
|
$ |
121.2 |
|
|
$ |
186.2 |
|
|
Direct commission income |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Affiliated entities |
|
143.4 |
|
|
76.6 |
|
|
— |
|
|
|
220.0 |
|
|
|
— |
|
|
|
(220.0 |
) |
|
|
— |
|
|
Unaffiliated entities |
|
14.8 |
|
|
24.1 |
|
|
— |
|
|
|
38.9 |
|
|
|
— |
|
|
|
— |
|
|
|
38.9 |
|
|
Net earned premiums |
|
— |
|
|
— |
|
|
155.5 |
|
|
|
155.5 |
|
|
|
— |
|
|
|
— |
|
|
|
155.5 |
|
|
Net investment income |
|
0.7 |
|
|
2.9 |
|
|
23.3 |
|
|
|
26.9 |
|
|
|
0.7 |
|
|
|
— |
|
|
|
27.6 |
|
|
Net realized gains on investments |
|
— |
|
|
— |
|
|
0.5 |
|
|
|
0.5 |
|
|
|
— |
|
|
|
— |
|
|
|
0.5 |
|
|
Net unrealized (losses) gains on investments |
|
— |
|
|
— |
|
|
(0.8 |
) |
|
|
(0.8 |
) |
|
|
4.0 |
|
|
|
— |
|
|
|
3.2 |
|
|
Segment revenues |
|
158.9 |
|
|
103.6 |
|
|
243.5 |
|
|
|
506.0 |
|
|
|
4.7 |
|
|
|
(98.8 |
) |
|
|
411.9 |
|
|
Losses and loss adjustment expenses |
|
— |
|
|
— |
|
|
111.6 |
|
|
|
111.6 |
|
|
|
— |
|
|
|
— |
|
|
|
111.6 |
|
|
Amortization of deferred acquisition costs |
|
— |
|
|
— |
|
|
77.4 |
|
|
|
77.4 |
|
|
|
— |
|
|
|
(15.4 |
) |
|
|
62.0 |
|
|
General and administrative expenses |
|
45.7 |
|
|
76.6 |
|
|
70.2 |
|
|
|
192.5 |
|
|
|
20.6 |
|
|
|
(41.4 |
) |
|
|
171.7 |
|
|
Adjusted EBITDA |
$ |
113.2 |
|
$ |
27.0 |
|
$ |
(15.7 |
) |
|
$ |
124.5 |
|
|
$ |
(15.9 |
) |
|
$ |
(42.0 |
) |
|
$ |
66.6 |
|
|
Interest expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(9.1 |
) |
||||||||||
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
(16.2 |
) |
||||||||||
|
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(6.3 |
) |
||||||||||
|
Net foreign exchange losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(3.6 |
) |
||||||||||
|
Other expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
(22.4 |
) |
||||||||||
|
Income before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
9.0 |
|
||||||||||
|
Reconciliation of GAAP to Non-GAAP Financial Results (in millions) (unaudited) |
|||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
(in millions) |
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Net income (loss) |
$ |
(1,367.0 |
) |
|
$ |
9.4 |
|
|
$ |
(1,346.1 |
) |
|
$ |
2.3 |
|
|
Adjustments: |
|
|
|
|
|
|
|
||||||||
|
Profits interest distribution expenses |
|
1,379.7 |
|
|
|
— |
|
|
|
1,379.7 |
|
|
|
— |
|
|
Share-based compensation expenses |
|
27.0 |
|
|
|
2.5 |
|
|
|
32.4 |
|
|
|
6.3 |
|
|
Other expenses |
|
45.6 |
|
|
|
8.0 |
|
|
|
70.6 |
|
|
|
22.4 |
|
|
Tax effect of adjustments to net income (loss) (1) |
|
(5.5 |
) |
|
|
(0.9 |
) |
|
|
(9.1 |
) |
|
|
(3.7 |
) |
|
Adjusted net income |
$ |
79.8 |
|
|
$ |
19.0 |
|
|
$ |
127.5 |
|
|
$ |
27.3 |
|
|
Adjustments: |
|
|
|
|
|
|
|
||||||||
|
Add back tax effect of adjustments to net income (loss) |
|
5.5 |
|
|
|
0.9 |
|
|
|
9.1 |
|
|
|
3.7 |
|
|
Income tax expense (benefit) |
|
9.5 |
|
|
|
(8.1 |
) |
|
|
26.4 |
|
|
|
6.7 |
|
|
Interest expenses |
|
2.6 |
|
|
|
3.1 |
|
|
|
7.7 |
|
|
|
9.1 |
|
|
Depreciation and amortization |
|
10.0 |
|
|
|
5.8 |
|
|
|
25.7 |
|
|
|
16.2 |
|
|
Net foreign exchange (gains) losses |
|
(2.4 |
) |
|
|
5.4 |
|
|
|
14.9 |
|
|
|
3.6 |
|
|
Adjusted EBITDA |
$ |
105.0 |
|
|
$ |
26.1 |
|
|
$ |
211.3 |
|
|
$ |
66.6 |
|
|
Total revenues |
|
267.4 |
|
|
|
153.7 |
|
|
|
664.5 |
|
|
|
411.9 |
|
|
Adjusted EBITDA margin |
|
39 |
% |
|
|
17 |
% |
|
|
32 |
% |
|
|
16 |
% |
|
(1) |
The tax effect of other expenses adjustments to net income (loss) for each period presented were calculated using the statutory tax rates for each of our legal entities where the expenses were incurred, including certain non-taxing jurisdictions. The statutory tax rates used in the calculations were adjusted in instances where our legal entities have applied full valuation allowances to their respective deferred tax assets of unutilized NOLs. As such, the tax effect for the respective years varies based on the jurisdictional mix of where the expenses were incurred in each year. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20251112020023/en/
Investor Relations
[email protected]
Accelerant
[email protected]
Media Relations
[email protected]
Source:



Neptune Insurance Holdings Inc. Reports Third Quarter 2025 Results
The Latest: House returns to vote on ending the government shutdown after nearly 2 months away
Advisor News
- Midlife planning for women: why it matters and how advisors should adapt
- Tax anxiety is real, although few have a plan to address it
- Trump targets ‘retirement gap’ with new executive order
- Younger investors are engaged and advisors must adapt
- Plugging the hidden budget leaks of retirement
More Advisor NewsAnnuity News
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
- Transamerica introduces RILA with optional income features
- American Life expands into Wyoming and Mississippi markets
More Annuity NewsHealth/Employee Benefits News
- North Dakota small business owners lament rising healthcare costs, credit card swipe fees
- NC's new Medicaid 'compromise' comes at a cruel and frightful cost
- VA to host claims and enrollment clinic in Hutch
- Data from Brown University Provide New Insights into Managed Care (Substantial Variation In Administrative Spending and Profit Across State Insurance Markets, 2023): Managed Care
- Studies from Parth Sheth et al in the Area of Epidemiology Described (Graphical Structure Learning Identifies Hypothesized Mechanisms for Heterogeneous Treatment Effects in Medicaid Population Health Programs): Health and Medicine – Epidemiology
More Health/Employee Benefits NewsLife Insurance News
- Genworth Financial Announces First Quarter 2026 Results
- Transamerica agrees to $57M settlement in cost-of-insurance lawsuit
- The next step for AI in insurance — partnerships to scale
- Your clients are sitting on underused assets
- National Life Group Names Jason Doiron CEO of NLG Capital to Lead the Next Phase of Growth
More Life Insurance News